Difference between revisions of "Osteoporosis"
From Testiwiki
(→Definition) |
(→Definition) |
||
Line 37: | Line 37: | ||
| Current therapeutic research 1996, vol. 57, no2, pp. 110-122. | | Current therapeutic research 1996, vol. 57, no2, pp. 110-122. | ||
|---- | |---- | ||
− | {| {{prettytable}} | + | {| {{prettytable}} style="background:#ABCDEF;" |
| Prevalence of osteoporosis at the age intervals shown in | | Prevalence of osteoporosis at the age intervals shown in | ||
|---- | |---- | ||
Line 109: | Line 109: | ||
| 310.9 | | 310.9 | ||
|---- | |---- | ||
− | |} | + | |} |
| Sweden, osteoporosis, paper contains other tables and data | | Sweden, osteoporosis, paper contains other tables and data | ||
| WHO criteria | | WHO criteria |
Revision as of 11:11, 29 June 2010
This page is a variable.
The page identifier is Op_en4523 |
---|
Moderator:Teemu R (see all) |
Give your opinion to the peer rating of the content of this page. |
Upload data
|
Scope
What is the prevalence of osteoporosis in the general population?
Definition
Spain: ~2 million women with osteoporosis; prevalent in 26.1% of women 50+ | ||||
Contains information on fractures and prevalence of osteoporosis across Europe with references for each of the facts | International Osteoporosis Foundation | |||
http://www.iofbonehealth.org/facts-and-statistics.html | ||||
7.8 million affected (6.5 million women) | Germany, 2003 | Claims data for patients with osteoporosis (M80, M81) or an osteoporosis-related fracture diagnosis (S22, S32, S42, S52, S72, S82) or treatment with anti-osteoporosis drugs | Epidemiology, treatment and costs of osteoporosis in Germany – the BoneEVA Study; Osteoporosis Int. 2007 v.18(1):77-84 | |
40.8% in women >50 and 17.7% in men >50 | Denmark, 1995-1999 | Based on normal Danish values for BMD, the expected number of subjects aged 50 years + with osteoporosis according to the WHO definition was calculated | Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark; Osteoporos Int. 2005 Feb;16(2):134-41. | |
Women, 45-59yrs | ||||
5.0% had a BMD <2.5 SD of the mean premenopausal reference value and were thus considered to be osteoporotic. | ||||
Patients were classified as slow (41.7%), borderline (28.2%), and fast (30.1%) bone losers. | ||||
By integrating the estimated annual percent bone loss with baseline bone mineral content, 27.6% of the postmenopausal women were identified as at risk of developing osteoporosis at age 65 years. | n=2286, Italy, risk of osteoporosis | Risk of osteoporosis by combining a baseline distal forearm bone mineral content measurement with an estimation of annual percent bone loss as shown by plasma bone Gla protein, serum alkaline phosphatase, and fasting urinary creatinine-corrected calcium and hydroxyproline | AGNUSDEI D. CALCAGNO V. CHRISTIANSEN C. CREPALDI G. GENNARI C. MARTINI L. MAZZUOLI G. F. PASQUARELLI V. Prevalence of osteoporosis and prediction of osteoporosis risk in Italian peri- and postmenopausal women : The detection of osteoporosis risk (door) study. | |
Current therapeutic research 1996, vol. 57, no2, pp. 110-122. |
Prevalence of osteoporosis at the age intervals shown in | ||||
Sweden using female-derived reference ranges at the femoral neck. | ||||
(Reprinted from [24) | ||||
Men | Women | |||
Age range | %of | Number | %of | Number |
(years) | population | affected (000) | population | affected (000) |
50–54 | 2.5 | 7.0 | 6.3 | 17.0 |
55–59 | 3.5 | 7.6 | 9.6 | 21.1 |
60–64 | 5.8 | 11.4 | 14.3 | 30.0 |
65–69 | 7.4 | 14.2 | 20.2 | 43.7 |
70–74 | 7.8 | 14.6 | 27.9 | 63.0 |
75–79 | 10.3 | 13.7 | 37.5 | 68.3 |
80–84 | 16.6 | 14.7 | 47.2 | 67.8 |
50–80 | 6.3 | 83.2 | 21.2 | 310.9 |
Result
See also
Related files
<mfanonymousfilelist></mfanonymousfilelist>